You expected amoxicillin and walked out with doxycycline. For sinus infections and pneumonia, that swap is written into US guidelines: doxycycline sits one rung below the first choice, and there are specific reasons a prescriber climbs down to it.
Most people who search for this have just been handed a doxycycline prescription for a respiratory infection and wonder whether they got a lesser drug. Often the reason is simple, such as a penicillin allergy listed in the chart. Sometimes it is about which bacteria the prescriber is trying to cover. Either way, both the sinusitis and the pneumonia guidelines name doxycycline explicitly, and they are also clear about where it does not belong.
For bacterial sinusitis in adults, guidelines put amoxicillin or amoxicillin/clavulanate first and list doxycycline as an alternative, especially with penicillin allergy. For pneumonia in healthy adults treated at home, the 2019 guideline lists amoxicillin first (strong recommendation) and doxycycline as a conditional option. In young children, the label limits doxycycline to severe or life-threatening situations, and pregnancy calls for a separate conversation.
The guideline ladder
The table lines up the first choice, the alternatives and doxycycline’s position for each situation. It summarizes the IDSA 2012 rhinosinusitis guideline, CDC’s adult outpatient guidance and the 2019 ATS/IDSA pneumonia guideline.
| Situation | First choice | Alternatives | Where doxycycline sits |
|---|---|---|---|
| Bacterial sinusitis, adult, no allergy | Amoxicillin or amoxicillin/clavulanate (CDC); IDSA prefers amoxicillin/clavulanate | Doxycycline; respiratory fluoroquinolone | IDSA: “may be used as an alternative regimen” (weak recommendation, low-quality evidence) |
| Bacterial sinusitis, adult, penicillin allergy | Doxycycline or a respiratory fluoroquinolone (levofloxacin, moxifloxacin) | Macrolides are not recommended (CDC, IDSA) | A first choice in this group (IDSA strong recommendation) |
| Bacterial sinusitis, child | Amoxicillin or amoxicillin/clavulanate (CDC) | Other agents chosen by the pediatrician | IDSA: “not suitable for children” |
| Pneumonia, healthy adult outpatient | Amoxicillin (strong recommendation, moderate-quality evidence) | Macrolide only where pneumococcal macrolide resistance is under 25% | Conditional recommendation, low-quality evidence |
| Pneumonia, outpatient with chronic illness | Amoxicillin/clavulanate or a cephalosporin plus a macrolide or doxycycline; or a respiratory fluoroquinolone alone | Choice depends on allergies and recent antibiotics | The add-on partner instead of a macrolide (conditional, low-quality evidence) |
Two things stand out. Doxycycline never sits at the very top except for adults with penicillin allergy and sinusitis. And the strength of evidence behind it is rated low in both guidelines, which means it works in practice but has fewer head-to-head trials than amoxicillin.
Four common scenarios
An adult with a sinus infection that has lasted two weeks and a penicillin allergy on file. This is the textbook case. Symptoms persisting more than 10 days without improvement meet the bacterial criteria used by CDC and IDSA, and the allergy rules out amoxicillin. Doxycycline or a respiratory fluoroquinolone are the two named choices, and doxycycline is a reasonable pick here.
A healthy 40-year-old with pneumonia on a chest X-ray, treated at home. Amoxicillin is the strongest-rated option, but the guideline accepts doxycycline as a conditional alternative. A prescriber who wants to cover Mycoplasma as well, or who is working around an allergy, may choose doxycycline.
An adult with diabetes or chronic lung disease and pneumonia. Here doxycycline usually appears as a partner, not alone. The 2019 guideline pairs amoxicillin/clavulanate or a cephalosporin with a macrolide or with doxycycline, or uses a respiratory fluoroquinolone by itself. If you were given doxycycline plus a second antibiotic, this is likely why.
A 6-year-old with a sinus infection. Doxycycline is unlikely. The IDSA panel called it not suitable for children in this setting, and CDC names amoxicillin or amoxicillin/clavulanate as first-line for children with severe or worsening bacterial sinusitis.
Why a prescriber picks doxycycline
A penicillin allergy on the chart
This is the most common reason. Amoxicillin is a penicillin, so a recorded allergy pushes the prescriber to another class. For sinusitis, both CDC and IDSA name doxycycline or a respiratory fluoroquinolone for penicillin-allergic adults. CDC adds that macrolides such as azithromycin are not recommended because roughly 40% of Streptococcus pneumoniae are resistant to them; the 2012 IDSA guideline cited about 30%. Doxycycline avoids that resistance problem.
If your allergy label is old or vague, it is worth asking whether it has ever been confirmed. Our guide to penicillin allergy labels and testing covers that question.
Coverage of “atypical” bacteria
Pneumonia can be caused by bacteria that amoxicillin does not reach, such as Mycoplasma pneumoniae. The current doxycycline hyclate label lists “respiratory tract infections caused by Mycoplasma pneumoniae” among its indications, and it also lists respiratory infections from Haemophilus influenzae and upper respiratory infections from S. pneumoniae when testing shows the strain is susceptible.
The pneumonia panel described its doxycycline recommendation as “based on limited clinical trial data, but a broad spectrum of action, including the most common relevant organisms.” It recommended amoxicillin “despite presumed lack of coverage of this antibiotic for atypical organisms.” In other words, the guideline accepts either path for a healthy adult, and the prescriber weighs the likely germ, local resistance and the patient’s history.
Resistance and recent antibiotics
The IDSA sinusitis panel said doxycycline “remains highly active against respiratory pathogens.” For sinusitis, where macrolides are ruled out, doxycycline is the only oral option named for penicillin-allergic adults besides the fluoroquinolones. A course of amoxicillin in the recent past can also shift the choice.
When doxycycline is usually not the pick
Young children. The label warns that tetracycline-class drugs given during tooth development, from the last half of pregnancy through infancy and childhood to age 8, may cause permanent yellow-gray-brown tooth discoloration, and that enamel hypoplasia has been reported. It says to use doxycycline in children 8 years or younger “only when the potential benefits are expected to outweigh the risks in severe or life-threatening conditions (e.g., anthrax, Rocky Mountain spotted fever), particularly when there are no alternative therapies.” For a child’s sinus infection, CDC’s pediatric guidance names amoxicillin or amoxicillin/clavulanate as first-line.
Pregnancy. The label says tetracyclines cross the placenta and have shown toxic effects on the developing fetus in animal studies. It also cites an expert review (TERIS) that concluded therapeutic doses in pregnancy are unlikely to pose a substantial risk of birth defects, while noting the data are limited and insufficient to say there is no risk. If you are pregnant or could be, tell the prescriber before starting; for respiratory infections, other first-line options exist.
When no antibiotic is needed. CDC estimates that 90-98% of sinus infections are viral and encourages watchful waiting for uncomplicated cases with reliable follow-up. Doxycycline does nothing for a cold or for most chest colds.
The 2019 pneumonia guideline notes that most patients reach clinical stability within 48 to 72 hours. If breathing gets harder, fever climbs or you feel worse rather than better, contact the prescriber the same day or seek urgent care, because the diagnosis or the drug may need to change.
What to mention before you start
- Any pregnancy, possible pregnancy or breastfeeding.
- The age of the patient, if the prescription is for a child.
- Every antibiotic taken in the past few months, including for acne.
- Supplements and antacids you take daily, since minerals can interfere with absorption.
- Trouble swallowing pills or a history of reflux, which matters for throat irritation.
- Whether your penicillin allergy was ever confirmed.
Label cautions in brief
Doxycycline has a few handling quirks that matter more than with amoxicillin. Pills that stick in the throat can cause painful esophageal irritation; our guide to preventing doxycycline pill esophagitis explains why. Sun sensitivity and interactions with minerals in dairy, antacids and supplements are covered in doxycycline with food, dairy and sun. The label also lists C. difficile-associated diarrhea, as with nearly all antibiotics. For the full range of uses, see what doxycycline is used for.
Questions people ask
Is doxycycline weaker than amoxicillin for a sinus infection?
Not in the sense of strength. The guidelines rank it as an alternative because the evidence base is smaller, not because it is known to fail more often. For adults with penicillin allergy, it is one of two first choices.
Does doxycycline treat walking pneumonia?
“Walking pneumonia” is an informal term, often used for milder pneumonia that may be caused by Mycoplasma. The label lists Mycoplasma pneumoniae respiratory infections as an indication, and the pneumonia guideline includes doxycycline for healthy outpatients. Only the clinician who examined you can say what kind of pneumonia you have.
Why did a friend get azithromycin for the same thing?
For sinusitis, CDC and IDSA advise against macrolides such as azithromycin because of pneumococcal resistance. For pneumonia in healthy adults, the 2019 guideline allows a macrolide only where resistance is under 25%. Prescribing habits vary, and a friend’s history may differ from yours.
What about bronchitis?
CDC states that routine antibiotic treatment of uncomplicated acute bronchitis is not recommended, regardless of how long the cough lasts. If you were told you have bronchitis and given doxycycline, ask what pointed toward a bacterial infection or pneumonia.
Can doxycycline be given to a child for sinusitis?
The IDSA guideline calls it “not suitable for children” for this purpose, and the label restricts use at age 8 and under to severe or life-threatening situations. Ask the pediatrician why it was chosen if a young child is prescribed it.
How does this compare with what amoxicillin covers?
Our companion piece on what amoxicillin treats walks through ear, throat, tooth and chest infections infection by infection.
Sources
- DailyMed: Doxycycline hyclate capsules, tablets and oral suspension label
- Chow et al., IDSA guideline for acute bacterial rhinosinusitis, Clin Infect Dis 2012
- Metlay et al., ATS/IDSA community-acquired pneumonia guideline, 2019
- CDC: Outpatient clinical care for adults
- CDC: Outpatient clinical care for pediatric populations
Evidence checked November 2, 2026. General information only; whether doxycycline fits your infection is your prescriber’s decision.